Reshma Shringarpure

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

Constantine S. Mitsiades, Nicholas Mitsiades, Ciaran J. McMullan et al. · Cancer Cell · 2004 · 610 citations

Hematological Malignancy, Solid Tumors, Medicine +9

Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications

Constantine S. Mitsiades, Nicholas Mitsiades, Ciaran J. McMullan et al. · Proceedings of the National Academy of Sciences · 2003 · 527 citations · Full text

Histone Modifications, Histone Deacetylases, Epigenetic Change +22

Ubiquitin Conjugation Is Not Required for the Degradation of Oxidized Proteins by Proteasome

Reshma Shringarpure, Tilman Grune, Jana Mehlhase et al. · Journal of Biological Chemistry · 2002 · 441 citations · Full text

Proteasome, Molecular Biology, S Proteasome +17

Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy

Éric Ravussin, Steven R. Smith, Julie A. Mitchell et al. · Obesity · 2009 · 326 citations · Full text